WHO ICTRP trial
Rucaparib MAintenance after Bevacizumab Maintenance following Carboplatin based…
EUCTR2019-000399-41-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2019-000399-41-DE |
|---|---|
| Public title | Rucaparib MAintenance after Bevacizumab Maintenance following Carboplatin based first line chemotherapy in Ovarian Cancer patients |
| Scientific title | Rucaparib MAintenance after Bevacizumab Maintenance following Carboplatin based first line chemotherapy in Ovarian Cancer patients - MAMOC |
| Primary sponsor | NOGGO e. V. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | This is a multicenter, randomized, placebo controlled, double blind study including patients with patients with histologically confirmed, advanced (FIGO stage IIIB, IIIC, or IV of the 2014 FIGO classification) high grade serous or high… |
| Interventions | Trade Name: Rubraca 200 mg film-coated tablets Product Name: Rucaparib 200 mg Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Rucaparib CAS Number: 283173-50-2 Current Sponsor code: CO-338 Other descriptive name: RUCAPARIB… |
| Registration date | Jun 26, 2019 |
| Target size | 190 |
| Secondary IDs | NOGGO-ov42 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: